Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pipeline Analysis

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1793822

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1793822

Shigella Test Kits

PUBLISHED:
PAGES: 371 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Shigella Test Kits Market to Reach US$145.0 Million by 2030

The global market for Shigella Test Kits estimated at US$110.1 Million in the year 2024, is expected to reach US$145.0 Million by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Lateral Flow Assays Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$55.5 Million by the end of the analysis period. Growth in the Enzyme-linked Immunosorbent Assay Test segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.0 Million While China is Forecast to Grow at 7.7% CAGR

The Shigella Test Kits market in the U.S. is estimated at US$30.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$28.9 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Shigella Test Kits Market - Key Trends & Drivers Summarized

What Is Driving Innovation in Shigella Diagnostics and Test Kit Development?

The Shigella test kits market is evolving rapidly due to rising global awareness about the burden of shigellosis, especially in children under five and in regions with inadequate sanitation infrastructure. Traditional culture-based methods, although accurate, are being replaced by molecular and immunoassay-based diagnostic kits that provide faster and more specific detection. Lateral flow immunoassays, real-time PCR assays, and ELISA-based kits are being increasingly adopted by clinical laboratories and public health institutions for rapid outbreak detection and treatment monitoring. These kits target multiple serogroups and subtypes, often distinguishing between Shigella and closely related pathogens like enteroinvasive E. coli (EIEC).

Technological advancement in multiplex diagnostics is reshaping the competitive landscape, with the emergence of syndromic panels that detect Shigella alongside other gastrointestinal pathogens in a single assay. The demand for point-of-care diagnostics, particularly in refugee camps, emergency clinics, and low-resource settings, is driving the development of portable and battery-powered test kits that require minimal training and yield results within 30 minutes. Companies are investing in microfluidic-based systems and CRISPR-enabled diagnostics for field-based deployment and high-sensitivity detection. Additionally, the development of lyophilized reagents and ambient-temperature-stable kits is reducing reliance on cold chain logistics in tropical regions.

How Are Global Health Initiatives and Regional Disease Surveillance Programs Influencing Market Adoption?

Global public health initiatives by organizations such as the WHO, CDC, and Gavi are exerting a strong influence on the demand for standardized, scalable, and affordable Shigella test kits. Shigella is classified as a priority pathogen under the WHO-s R&D Blueprint due to its growing antimicrobial resistance (AMR), which has made fast diagnosis critical for stewardship and containment. Mass vaccination trials and surveillance programs across sub-Saharan Africa, South Asia, and Southeast Asia are creating large-scale opportunities for diagnostic manufacturers, especially those offering PCR and ELISA-based surveillance platforms aligned with global health guidelines.

Regional governments and non-profit health alliances are scaling up disease surveillance networks, particularly targeting schools, slums, and refugee camps. In these settings, test kits that are easy to use, deliver accurate results, and support epidemiological reporting are prioritized. Diagnostic developers are responding by integrating digital readout interfaces, cloud-based reporting, and app-connected readers to ensure data standardization and integration into national disease databases. Kits with WHO prequalification or CE-IVD approval are more readily adopted in donor-funded programs. Moreover, the inclusion of Shigella in Integrated Disease Surveillance and Response (IDSR) frameworks is influencing public procurement volumes across Africa and South Asia.

What Regulatory and Technical Challenges Impact Product Accessibility and Use?

The Shigella test kit market is challenged by multiple regulatory, technical, and operational hurdles, particularly in the context of cross-border use, pathogen strain variability, and quality assurance. Shigella comprises multiple serogroups-S. dysenteriae, S. sonnei, S. flexneri, and S. boydii-which often co-circulate in different geographies and respond differently to treatments. This diversity necessitates kits that detect broad strain repertoires with high sensitivity and specificity, while minimizing cross-reactivity with other enteric pathogens. Test developers are also grappling with the need for greater harmonization of performance benchmarks, especially as many test kits are deployed in informal or field settings with limited infrastructure.

Access to quality diagnostics is hindered in many low- and middle-income countries due to customs regulations, lack of local validation studies, and limited reimbursement mechanisms for diagnostic testing. In some cases, national essential diagnostics lists have yet to include Shigella as a standalone test item, reducing institutional adoption. Additionally, the accuracy of point-of-care tests is often dependent on adherence to handling protocols, ambient conditions, and reagent quality-factors that can vary significantly across deployment environments. To address these gaps, manufacturers are working on integrated kits with built-in controls, buffer systems, and error-proof sample processing modules to reduce variability.

Efforts to improve diagnostic access include regional manufacturing hubs, technology transfer programs, and public-private partnerships aimed at subsidizing test kit procurement for high-burden areas. Third-party proficiency testing programs and external quality assessment schemes are also gaining traction to build confidence in local testing accuracy. Moreover, test kit companies are increasingly bundling their products with training modules and maintenance services for diagnostic capacity-building in underserved regions.

What Are the Primary Forces Propelling Growth in the Shigella Test Kits Market?

The growth in the global Shigella test kits market is driven by several factors that reflect the increasing prioritization of enteric disease diagnostics and rapid infectious disease surveillance. A primary growth driver is the rising incidence of shigellosis in both endemic and travel-associated populations, which has heightened the need for fast, reliable, and decentralized diagnostic solutions. With mounting antimicrobial resistance among Shigella strains, timely and precise identification of the causative agent is critical for effective treatment decisions and outbreak containment. Consequently, hospitals, clinics, and public health institutions are investing in diagnostic kits that align with AMR surveillance frameworks and WHO treatment guidelines.

Another major driver is the expansion of diagnostic infrastructure and funding across developing nations. Large-scale health surveys, donor-funded sanitation programs, and nutrition-focused child health campaigns are generating steady demand for Shigella test kits. The integration of diagnostic testing into routine immunization, prenatal screening, and school-based hygiene programs is expanding the use case for rapid and portable diagnostic tools. Multinational aid agencies and foundations are increasingly incorporating diagnostics into their WASH (Water, Sanitation, and Hygiene) program supply chains, recognizing the critical link between waterborne pathogens and undernutrition in children.

The growth trajectory is also supported by technological advancements in portable diagnostics, including isothermal amplification platforms, smartphone-enabled assays, and AI-driven result interpretation. These innovations are reducing the skill threshold and infrastructure requirements for accurate testing, thereby unlocking new end-user segments in mobile clinics, emergency response teams, and community health worker programs. As diagnostics become more integrated into broader public health interventions, the Shigella test kits market is expected to benefit from both vertical and horizontal demand across health systems.

SCOPE OF STUDY:

The report analyzes the Shigella Test Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test, Other Test Types); Technology (Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology, Other Technologies); End-Use (Hospitals End-Use, Diagnostic Laboratories End-Use, Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Alere Inc. (Abbott)
  • BioMerieux SA
  • BioPerfectus (BioPerfectus Tech)
  • Bio-Rad Laboratories, Inc.
  • Cepheid (Danaher)
  • Coris BioConcept
  • Creative Diagnostics
  • CTK Biotech, Inc.
  • DiaSorin S.p.A.
  • Fujirebio Diagnostics, Inc.
  • Hardy Diagnostics
  • Hygiena LLC
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • MP Biomedicals LLC
  • QIAGEN N.V.
  • Sekisui Diagnostics LLC
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP38006

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Shigella Test Kits - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Shigella Infections Throws the Spotlight on Rapid Diagnostic Solutions
    • Expansion of Food Safety Regulations Propels Adoption of Shigella Test Kits in Commercial Kitchens
    • Surge in Travel-Associated Gastrointestinal Disorders Drives Market Demand for Point-of-Care Testing
    • Advancements in Molecular Diagnostic Technologies Strengthen Business Case for PCR-Based Kits
    • Growth of Decentralized Diagnostics Accelerates Demand for At-Home and Field-Use Testing Solutions
    • Increased Focus on Early Detection in Pediatric and Geriatric Populations Spurs Diagnostic Expansion
    • Integration of AI-Powered Interpretation Tools Enhances Accuracy and Speed of Test Kits
    • Public Health Surveillance Programs Create Institutional Demand Across Urban and Rural Health Clinics
    • Growing Preference for Multiplex Pathogen Panels Boosts Bundled Testing Capabilities
    • Regulatory Approvals for Low-Cost Rapid Kits Strengthen Market Accessibility in Emerging Economies
    • Heightened Risk of Foodborne Illness in Mass Catering and Hospitality Drives Routine Screening Adoption
    • Strategic Stockpiling for Outbreak Preparedness Sustains Demand From Health Ministries and NGOs
    • Integration With Electronic Health Records Improves Case Tracking and Clinical Response
    • Educational Campaigns Around Waterborne Diseases Expand Awareness and Screening Compliance
    • Proliferation of Telemedicine and Remote Diagnostics Enhances Distribution of Home-Use Test Kits
    • Partnerships With Food Safety and Hygiene Monitoring Agencies Support Institutional Adoption
    • Development of Paper-Based and Disposable Test Formats Promotes Single-Use Applications
    • COVID-Era Investments in Diagnostic Infrastructure Spill Over Into Enteric Disease Detection
    • Increased Research Funding in Antimicrobial Resistance Encourages Test-Kit Innovation
    • Mobile Health Initiatives and Community Health Workers Expand Rural Reach of Shigella Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Shigella Test Kits Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Shigella Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Lateral Flow Assays Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Lateral Flow Assays Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Lateral Flow Assays Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Enzyme-linked Immunosorbent Assay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Enzyme-linked Immunosorbent Assay Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction Assay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Polymerase Chain Reaction Assay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Polymerase Chain Reaction Assay Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Conventional Diagnostic Tests Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Conventional Diagnostic Tests Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Conventional Diagnostic Tests Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Nucleic Acid-based Tests Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Nucleic Acid-based Tests Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Nucleic Acid-based Tests Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • JAPAN
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • CHINA
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: China 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • EUROPE
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Shigella Test Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • FRANCE
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: France 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • GERMANY
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Shigella Test Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • INDIA
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: India 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Shigella Test Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Shigella Test Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
  • AFRICA
    • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!